by Lefere, Sander, Devisscher, Lindsey and Tacke, Frank
Reference:
S. Lefere, L. Devisscher and F. Tacke, "Targeting CCR2/5 in the treatment of nonalcoholic steatohepatitis (NASH) and fibrosis", Expert opinion on investigational drugs, vol. 29, no. 2, 2020, pp. 89–92.
Bibtex Entry:
@article{Lefere:788068,
author = {Lefere, Sander and Devisscher, Lindsey and Tacke, Frank},
title = {Targeting {CCR}2/5 in the treatment of nonalcoholic steatohepatitis ({NASH}) and fibrosis},
journaltitle = {Expert opinion on investigational drugs},
year = {2020},
doi = {10.1080/13543784.2020.1718106},
keywords = {,CRC1382-Project B05},
location = {Abingdon, Oxon},
note = {SFB 1382: Die Darm-Leber-Achse -- Funktionelle Zusammenhänge und therapeutische Strategien (403224013)},
number = {2},
pages = {89--92},
publisher = {Routledge, Taylor \& Francis},
pubmed = {pmid:31952447},
reportid = {RWTH-2020-04416},
subtitle = {Opportunities and challenges},
url = {https://publications.rwth-aachen.de/record/788068},
volume = {29},
}